PARP1 and PARP2 enzymes — Drug Target

All drugs that target PARP1 and PARP2 enzymes — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

PARP inhibitor

Marketed (1)

• Talzenna · Pfizer Inc. · PARP inhibitor · Oncology
  PARP1/PARP2 inhibitor causing DNA damage, decreased proliferation, and apoptosis in BRCA-mutated cancers.